Detalhe da pesquisa
1.
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.
JAMA
; 329(16): 1356-1366, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060545
2.
A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease.
Blood Cells Mol Dis
; 39(1): 115-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17391996